Ask Onix
Luxury clinics market ageing as a manageable condition
The burgeoning longevity industry sells the idea that biological ageing can be slowed-or even reversed-through advanced diagnostics and personalised interventions. But as high-end clinics proliferate, critics question whether the science justifies the cost.
A day of diagnostics: Inside a premium longevity clinic
At Biograph, a clinic with locations in New York City and San Francisco, clients undergo a six-hour assessment gathering over 1,000 data points from 30 diagnostics. The process includes proprietary MRI and CT scans, body composition analysis, VO2 max testing, and comprehensive bloodwork. Afterward, clients receive a personalised health risk profile synthesising all findings.
Michael Doney, Biograph's executive medical director, distinguishes his clinic from broader wellness offerings. "Longevity here means extending healthspan and lifespan by identifying risks early, often years before symptoms appear," he said. One in six members uncovers urgent or potentially life-threatening findings, he added.
Longevity goes mainstream in luxury hospitality
The industry is expanding beyond standalone clinics. In Grand Cayman, Meraki Wellness, a 16,000-square-foot destination, opens this spring, while St. Barth's Le Barthélemy Hotel now pairs biological age testing with seaside mindfulness sessions. Switzerland's Clinique La Prairie offers "Life Reset," combining diagnostics with personalised nutrition and stress-resilience therapies.
Hotels are also embedding longevity protocols into guest experiences. The Four Seasons Los Angeles at Beverly Hills introduced Flight Check, a $1,000 medical-grade recovery protocol for air travel's physiological toll. Developed with Immortelle Integrative Health, the 60-minute session includes IV therapy, laser-based immune fortification, and light therapy targeting brain function. Add-ons like genetic analysis and stem cell therapy are available for additional fees.
"Flying creates this perfect storm of immune suppression that people don't realise they need to recover from," said Jessica Jacobson, Immortelle's co-founder and director of patient care.
Jessica Jacobson, Immortelle Integrative Health
Science lags behind the hype
Experts caution that many interventions lack robust evidence. Deborah Kado, professor of medicine and geriatric research chief at Stanford Medicine, noted that while some biomarkers may offer useful health insights, "the key word is 'perhaps.'" She emphasised that assumptions about human longevity based on animal studies remain unproven.
Andrea LaCroix, professor at UC San Diego's Herbert Wertheim School of Public Health, was blunt: "There's an absence of clinical trial data showing that any interventions extend healthy longevity in humans." She described the treatments as "self-experimentation at your own risk."
Costs raise equity concerns
Prices vary widely, from $200 for basic wellness screenings to $1,300 for a 45-minute "cellular repair" session. Annual programmes can exceed several thousand dollars, raising questions about accessibility. Kado highlighted a two-tier ageing system in the U.S., where preventative care is often sacrificed for basic needs.
"You don't have to be super wealthy to enjoy healthy longevity," Kado said. "I've cared for patients in their 80s to early 100s who aren't consumers of luxury services."
Deborah Kado, Stanford Medicine
Women's health emerges as a key market
Women represent a major demographic, with menopause-focused offerings becoming a distinct subcategory. Jessica Shepherd, a physician specialising in women's health, sees progress in breaking taboos but warns against exploitative pricing.
"The line gets crossed when women are made to feel they must invest thousands to protect their health," Shepherd said. "Menopause isn't something to be fixed-it's a transition to be supported."
Jessica Shepherd, Women's Health Physician
Industry calls for transparency
Melanie Goldey, CEO of Tally Health, advocates for accountability. "Longevity becomes problematic when companies charge large sums while overstating what science can deliver," she said. "Fair pricing means transparency about what's well-supported, evolving, or unknown."
Frank Lipman, an integrative medicine physician, offered a pragmatic view: "Science supports healthy diet, sleep, exercise, and stress management-yet many cutting-edge treatments remain unvalidated."
The future of longevity
As the industry grows, Shula Clarke, Meraki Wellness's co-founder, emphasised a holistic approach. "We're not a medical setting," she said. "Our data is a tool for insight, not diagnosis."
The debate continues: Can ageing truly be slowed, or is the longevity industry selling an aspirational illusion?
